As such, targeted interference of monocyte recruiting chemokines like CCL7, CCL8, or CXCL1 may help preserve the steady state monocyte:macrophage balance that is disrupted in pathological inflammatory states, such as IBD. Here, CXCL1 is linked to irritable bowel syndrome.